Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Risks : Hypoglycemia, especially during fasting
In other cases, talk to a knowledgeable clinician as soon as possible about your symptoms so you can get to the root cause and feel better
Patients must understand that the benefits seen with FDA-approved GLP1s may not always translate to their compounded counterparts
Potential redox cycling-based toxicity has been implicated with many compounds 7
Those taking sulfonylureas (such as glipizide or glimepiride) face hypoglycemia risk during fasting and should discuss dose reduction or temporary discontinuation with their provider
For those interested in the science behind these recommendations, check out this recent study published in Obesity that outlines optimal nutritional guidelines for people taking GLP-1 medications for weight loss
)
&srotate=0)
